Used in pharmaceutical research as a potent inhibitor of specific kinases involved in inflammatory and autoimmune diseases. Shows promise in modulating signaling pathways related to rheumatoid arthritis and psoriasis. Its structure allows selective binding to target enzymes, improving therapeutic efficacy with reduced off-target effects. Also investigated for anticancer activity due to its ability to interfere with cell proliferation pathways, including potential applications in lung, breast, and blood cancers. Solubility and stability properties make it suitable for oral formulation development. Currently in research stages and not widely approved for clinical use.